After Hours Summary: FIVE +11%, ULTA +6% following earnings/guidance... WDAY -12%,SWHC -6%, AMBA -6%, GPS -1% following earnings/guidance/SSS, SBUX -3.5% on CEO transition newsAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: FIVE +11.1%, ULTA +6.2%
Companies trading higher in after hours in reaction to news: CTIC +24.4% (announces results of a translational pharmacology study comparing biomarker activity profiles for three JAK inhibitors: pacritinib, ruxolitinib and momelotinib, using the BioMAP Diversity PLUS panel of in vitro human primary cell-based systems), NEWM +4.2% (ticking higher; to join the S&P SmallCap 600)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance/SSS: WDAY -11.9%, GIII -7.9%, SWHC -6.2%, AMBA -6.2%, ZUMZ -5.3% (also reported Nov same store sales of +5.7% vs -13.8% year ago and +10.2% last month), GPS -1.2%, (reported Nov same store sales of -1% vs -8% year ago)
Companies trading lower in after hours in reaction to news: ENSV -32.4% (announces an underwritten common stock offering), CVM -24.7% (announces proposed public offering of common stock and warrants), HMLP -8.4% (agrees to acquire a 51% interest in the FSRU Hoegh Grace for about $91.80 mln; proposes a possible quarterly dividend increase of 4-5% assuming the purchase is completed; announces public offering of 5,500,000 common units), INTX -7% (to cease operations of Pet Health Monitoring business to concentrate resources on identity and privacy protection services; Loeb Holding withdrew proposal regarding a possible acquisition of the Pet Health Monitoring Business), SM -4.4% (commences 8 mln common stock offering), FMSA -4.4% (files for mixed securities shelf offering and approx 71.1 mln share secondary offering by selling security holders), VBLT -3.8% (enters into separate equity distribution agreements to implement an at the market offering program under which it may offer and sell its ordinary shares having an aggregate offering price of up to $20 mln), SBUX -3.5% (confirms that effective April 3 Chairman & CEO Howard Schultz will be appointed Executive Chairman; Replacement CEO named), ATI -3.4% (suspends quarterly dividend effective immediately), HTBX -1.9% (modestly rebounding; also files for offering of 3,020,084 shares of common stock issuable upon exercise of outstanding warrants), JNJ -0.2% (light volume; indicated lower on unfavorable hip implant verdict news)
Closing Market Summary: Stocks Slip Ahead of November Employment ReportThe stock market ended Thursday on a mixed note ahead of Friday's Employment Situation report for November (consensus 180,000). The Dow Jones Industrial Average (+0.4%) continued its recent outperformance while the S&P 500 (-0.4%) and Nasdaq (-1.4%) ended in negative territory for the second consecutive day. The Nasdaq extended its weekly decline to 2.7%, settling just below its 50-day moving average (5264) for the first time since November 14.
Equity indices started above their flat lines, but countercyclical sectors and the top-weighted technology group displayed relative weakness from the start. The underperformance in the tech sector took a toll on the Nasdaq Composite while the broader S&P 500 benefited from solid gains in three cyclical groups.
The technology sector (-2.3%), which accounts for nearly 21.0% of the S&P 500, was pressured by daylong selling among high-beta chipmakers. The PHLX Semiconductor Index lost 4.9% with Apple (AAPL 109.47, -1.05) suppliers leading the decline after reports that the tech giant was reducing orders for the iPhone 7 due to weak demand. Apple fell 1.0% while Broadcom (AVGO 162.79, -7.70), Cirrus Logic (CRUS 49.32, -5.68), Qualcomm (QCOM 64.16, -3.97), and Skyworks (SWKS 71.78, -5.07) lost between 4.5% and 10.3%. Following today's profit taking, the PHLX Semiconductor Index remains up 26.1% for the year.
The Nasdaq also had to contend with daylong weakness in biotechnology, which sent the iShares Nasdaq Biotechnology ETF (IBB 269.49, -4.58) lower by 1.7%. However, the broader health care sector (-0.8%) settled a bit closer to its flat line.
Similar to health care, three of the remaining four countercyclical groups spent the day in negative territory. The real estate sector (-1.6%) extended its fourth-quarter loss to 10.2% while utilities (-0.9%) and consumer staples (-0.7%) struggled as yields remained on the rise. The benchmark 10-yr yield rose six basis points to 2.44% while the 2-yr yield increased two basis points to 1.14%.
Besides pressuring defensively-oriented groups, the increase in yields was a supportive factor for the financial sector (+1.7%), which is now up 18.1% in the fourth quarter due to sharp steepening in the yield curve. Sector heavyweights Bank of America (BAC 21.50, +0.38) and JPMorgan Chase (JPM 81.79, +1.62) gained 1.8% and 2.0%, respectively.
Elsewhere on the cyclical side, energy (+0.3%) and industrials (+0.8%) continued their recent outperformance, but the energy sector slid from its high into the close. Crude oil also backed away from its best level of the day, but still settled higher by 3.3% at $51.06/bbl. The energy component is now within striking distance of its 2016 high ($51.93/bbl).
For the second day in a row, the industrial sector (+0.8%) received support from transport stocks. The Dow Jones Transportation Average climbed 0.6% with CSX (CSX 36.62, +0.81) ending among the leaders. Recall that the rail carrier raised its fourth-quarter guidance yesterday.
Today's NYSE floor volume was above the 200-day average of 926 million, as 1.1 billion shares changed hands.
Economic data included Initial Claims, Construction Spending, and ISM:
- Initial claims for the week ending November 26 increased 17,000 to 268,000 ( consensus 253,000), marking the 91st straight week they have been below 300,000
- Continuing claims for the week ending November 19 jumped by 38,000 to 2.081 million
- Construction spending increased 0.5% in October (consensus +0.6%) following an upwardly revised unchanged reading (from -0.4%) for September. This will be a positive input when computing Q4 GDP
- The ISM Manufacturing Index rose to 53.2 in November (consensus 52.1) from 51.9 in October
- This was the third straight month that manufacturing activity has expanded and it is the highest reading since June 2016
Tomorrow, the Employment Situation report for November (consensus 180,000) will be released at 8:30 ET.
- Russell 2000 +16.3% YTD
- Dow Jones Industrial Average +10.1% YTD
- S&P 500 +7.2% YTD
- Nasdaq Composite +4.9% YTD
In reaction to disappointing earnings/guidance:
- CBK +19.2%, TLYS +18.3%, SMTC +6%, LZB +5.4%, (also increases quarterly dividend by 10% to $0.11 per share), BOX+3.4%, VSM +2.5%
- NWY +1%, DSGX +0.7%, PVH +0.6%
Select EU financial related names showing strength: CS +3.4%, RBS +2.5%, BCS +1.2%, DB +1%
Select oil/gas related names showing early strength:
- TPLM +10.4%, LEI +9.8%, NAO +8.3%, SDRL +8.2%, WTI +6.5%, MRO +4.9%, CRC +4.6%, OAS +4.5%, CHK +4%,ESV +4%
- BAS +3.9%, REXX +3.7%, RIG +3.6%, RDS.A +1.9%, BP +1.8%
- BSTG +27.5% (confirms that its Cellspan Esophageal Implant was granted Orphan Drug Designation by the FDAg)
- BLUE +24% ( announces interim Phase 1 dose escalation data for Anti-BCMA CAR T product candidate in patients with relapsed/refractory multiple myeloma; 100% of patients in second and third dose cohorts achieved objective response; two patients MRD-negative; overall response rate 78%)
- FF +8.6% (declares a special cash dividend of $2.29/share)
- SKX +6.9% (CEO disclosed purchase of 500K shares worth more than $5.5 mln; also upgraded to Buy from Neutral at Buckingham Research)
- CLRB +6.7% (updates on the first two cohorts of its Phase I clinical study of CLR 131)
- CYTK +4.2% (announces that Amgen (AMGN) has started GALACTIC-HF)
- COL +3.5% (Starboard may push for Rockwell to reconsider its pending merger with BEAV)
- JUNO +3.2% (in sympathy with BLUE)
- KITE +3.1% (in sympathy with BLUE)
- PNLYY +2.9% (thinly traded ADR; PostNL acknowledges receipt of revised final proposal from bpost; is reviewing and considering bpost's revised conditional offer)
- MBLY +1.9% (initiated with a Buy at Needham; tgt $55 )
- ZIOP +1.5% (in sympathy with BLUE)
- WLL +7.2% (upgraded to Buy from Hold at Stifel)
- SMTC +6.8% (upgraded to Outperform from Perform at Oppenheimer)
- SM +4.3% (upgraded to Buy from Hold at Stifel)
- EOG +2% (upgraded to Buy from Hold at Stifel)
- APC +1.9% (upgraded to Buy from Hold at Stifel)
- DE +1.4% (upgraded to Buy from Neutral at BofA/Merrill)